Home Comparison of three different protocols for obtaining hemolysis
Article
Licensed
Unlicensed Requires Authentication

Comparison of three different protocols for obtaining hemolysis

  • Nora Nikolac Gabaj ORCID logo , Marijana Miler ORCID logo EMAIL logo , Alen Vrtaric ORCID logo , Ivana Celap ORCID logo , Marina Bocan , Petra Filipi , Vanja Radisic Biljak ORCID logo , Ana-Maria Simundic ORCID logo , Vesna Supak Smolcic ORCID logo and Marija Kocijancic ORCID logo
Published/Copyright: February 23, 2022

Abstract

Objectives

Hemolysis is associated with erroneous or delayed results. Objectives of the study were to compare four different methods for obtaining hemolysis in vitro on three different analyzers.

Methods

Hemolysis was prepared with addition of pure hemoglobin into serum pool, osmotic shock, aspiration through blood collection needle, freezing/thawing of whole blood. Biochemistry parameters were measured in duplicate at Architect c8000 (Abbott, Abbott Park, USA), Beckman Coulter AU680 (Beckman Coulter, Brea, USA) and Cobas 6000 c501 (Roche, Mannheim, Germany), according to manufacturers’ declarations. Cut-off value was defined as the highest value of H index with corresponding bias lower than acceptance criteria.

Results

We were not able to obtain results with freezing protocol. On all three platforms, lowest number of analytes were sensitive to hemolysis at H=0.5 using method of adding free hemoglobin. When osmotic shock was used, cut-off values for the most analytes were generally met at lower values. Hemolysis significantly interfered with measurement of potassium and lactate dehydrogenase (LD) at H=0.5 on all platforms. The most of the tested analytes had the lowest acceptable H index when aspiration method was used. At the low level of hemolysis (H=0.8) glucose, sodium, potassium, chloride, phosphate, and LD were affected on all analyzers, with some additional analytes depending on the manufacturer.

Conclusions

Hemolysis interference differs on different analyzers and according to protocol for obtaining hemolysis. Aspiration method was generally the most sensitive to hemolysis interference, while addition of free Hb was the most resistant.


Corresponding author: Marijana Miler, Working Group for Preanalytical Phase of the Croatian Society of Medical Biochemistry and Laboratory Medicine, Zagreb, Croatia; and Department of Clinical Chemistry, Sestre milosrdnice University Hospital Center, Zagreb, Croatia, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: The study was approved by the Ethical Committee of the Sestre milosrdnice University Hospital Center. For the study, samples were prepared from the remaining portions of serum and whole blood pools after routine laboratory testing was completed. Demographic, anamnestic or clinical data on patients were not collected.

References

1. Lippi, G, Salvagno, GL, Montagnana, M, Brocco, G, Guidi, GC. Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med 2006;44:311–6. https://doi.org/10.1515/CCLM.2006.054.Search in Google Scholar

2. Marques-Garcia, F. Methods for hemolysis interference study in laboratory medicine - a critical review. EJIFCC 2020;31:85–97.Search in Google Scholar

3. Dolci, A, Panteghini, M. Harmonization of automated hemolysis index assessment and use: is it possible? Clin Chim Acta 2014;432:38–43. https://doi.org/10.1016/j.cca.2013.10.012.Search in Google Scholar

4. Nikolac Gabaj, N, Miler, M, Vrtarić, A, Hemar, M, Filipi, P, Kocijančić, M, et al.. Precision, accuracy, cross reactivity and comparability of serum indices measurement on Abbott Architect c8000, Beckman Coulter AU5800 and Roche Cobas 6000 c501 clinical chemistry analyzers. Clin Chem Lab Med 2018;56:776–88. https://doi.org/10.1515/cclm-2017-0889.Search in Google Scholar

5. von Meyer, A, Cadamuro, J, Lippi, G, Simundic, AM. Call for more transparency in manufacturers declarations on serum indices: on behalf of the Working Group for Preanalytical Phase (WG-PRE), European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Clin Chim Acta 2018;484:328–32. https://doi.org/10.1016/j.cca.2018.03.043.Search in Google Scholar

6. Clinical and Laboratory Standards Institute (CLSI). Hemolysis, icterus, and lipemia/turbidity indices as indicators of interference in clinical laboratory analysis; approved guideline. CLSI document C56-A. Wayne, PE, USA: Clinical and Laboratory Standards Institute; 2012.Search in Google Scholar

7. Clinical Laboratory Standards Institute. Interference testing in clinical chemistry; approved guideline, 3rd ed. CLSI document EP07. Wayne, Pennsylvania, USA: Clinical Laboratory Standards Institute; 2018.Search in Google Scholar

8. Lippi, G. Interference studies: focus on blood cell lysates preparation and testing. Clin Lab 2012;58:351–5.Search in Google Scholar

9. Lippi, G, Salvagno, GL, Montagnana, M, Brocco, G, Cesare Guidi, G. Influence of the needle bore size used for collecting venous blood samples on routine clinical chemistry testing. Clin Chem Lab Med 2006;44:1009–14. https://doi.org/10.1515/CCLM.2006.172.Search in Google Scholar

10. Lippi, G, Musa, R, Aloe, R, Mercadanti, M, Pipitone, S. Influence of temperature and period of freezing on the generation of hemolysate and blood cell lysate. Clin Biochem 2011;44:1267–9. https://doi.org/10.1016/j.clinbiochem.2011.07.015.Search in Google Scholar

11. Gidske, G, Sølvik, UØ, Sandberg, S, Kristensen, GBB. Hemolysis interference studies: freeze method should be used in the preparation of hemolyzed samples. Clin Chem Lab Med 2018;56:e220–2. https://doi.org/10.1515/cclm-2018-0193.Search in Google Scholar

12. Ceriotti, F, Fernandez-Calle, P, Klee, GG, Nordin, G, Sandberg, S, Streichert, T, et al.. Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference. Clin Chem Lab Med 2017;55:189–94. https://doi.org/10.1515/cclm-2016-0091.Search in Google Scholar

13. American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care 2021;44(1 Suppl):S15–33. https://doi.org/10.2337/dc21-S002.Search in Google Scholar

14. National Kidney Foundation. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis 2015;66:884–930. https://doi.org/10.1053/j.ajkd.2015.07.015.Search in Google Scholar

15. Ricós, C, Alvarez, V, Cava, F, García-Lario, JV, Hernández, A, Jiménez, CV, et al.. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999;59:491–500. 10.1080/00365519950185229.10.1080/00365519950185229Search in Google Scholar PubMed

16. Gidske, G, Aakre, KM, Rustad, P, Sandberg, S, Norling, A, Pelanti, J, et al.. Handling of hemolyzed serum samples in clinical chemistry laboratories: the Nordic hemolysis project. Clin Chem Lab Med 2019;57:1699–711. https://doi.org/10.1515/cclm-2019-0366.Search in Google Scholar

17. Dimeski, G. Effects of hemolysis on the Roche ammonia method for Hitachi analyzers. Clin Chem 2004;50:976–7. https://doi.org/10.1373/clinchem.2003.028993.Search in Google Scholar

18. Delgado, JA, Morell-Garcia, D, Bauça, JM. Hemolysis interference studies: the particular case of sodium ion. EJIFCC 2019;30:25–34.Search in Google Scholar

19. Koseoglu, M, Hur, A, Atay, A, Cuhadar, S. Effects of hemolysis interferences on routine biochemistry parameters. Biochem Med 2011;21:79–85. https://doi.org/10.11613/bm.2011.015.Search in Google Scholar

20. Perović, A, Dolčić, M. Influence of hemolysis on clinical chemistry parameters determined with Beckman Coulter tests - detection of clinically significant interference. Scand J Clin Lab Invest 2019;79:154–9. https://doi.org/10.1080/00365513.2019.1576099.Search in Google Scholar

Received: 2021-11-23
Accepted: 2022-02-11
Published Online: 2022-02-23
Published in Print: 2022-04-26

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Lot-to-lot variation: no longer a neglected issue
  4. Review
  5. Health Technology Assessment to assess value of biomarkers in the decision-making process
  6. Mini Review
  7. Diagnostic performance of the fully automated Roche Elecsys SARS-CoV-2 antigen electrochemiluminescence immunoassay: a pooled analysis
  8. Opinion Papers
  9. Preanalytical quality improvement – an interdisciplinary journey
  10. Metrological traceability and clinical traceability of laboratory results – the role of commutability in External Quality Assurance
  11. Lot-to-lot reagent verification: challenges and possible solutions
  12. EFLM Paper
  13. An approach for determining allowable between reagent lot variation
  14. General Clinical Chemistry and Laboratory Medicine
  15. Introduction of BD Vacutainer® Barricor™ tubes in clinical biobanking and application of amino acid and cytokine quality indicators to Barricor plasma
  16. Delays during PBMC isolation have a moderate effect on yield, but severly compromise cell viability
  17. Investigation of the effects of pneumatic tube transport system on routine biochemistry, hematology, and coagulation tests in Ankara City Hospital
  18. Comparison of three different protocols for obtaining hemolysis
  19. Report from the HarmoSter study: impact of calibration on comparability of LC-MS/MS measurement of circulating cortisol, 17OH-progesterone and aldosterone
  20. Point-of-care testing in primary healthcare: a scoring system to determine the frequency of performing internal quality control
  21. Hematology and Coagulation
  22. The flagging features of the Sysmex XN-10 analyser for detecting platelet clumps and the impacts of platelet clumps on complete blood count parameters
  23. Cancer Diagnostics
  24. Thyroglobulin and thyroglobulin antibodies: assay-dependent management consequences in patients with differentiated thyroid carcinoma
  25. Infectious Diseases
  26. Hyris bCUBE SARS-CoV-2 rapid molecular saliva testing: a POCT innovation on its way
  27. Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection
  28. Identification of contagious SARS-CoV-2 infected individuals by Roche’s Rapid Antigen Test
  29. Monocyte distribution width (MDW) as a screening tool for early detecting sepsis: a systematic review and meta-analysis
  30. Perinatal asphyxia partly affects presepsin urine levels in non-infected term infants
  31. Letters to the Editors
  32. Spurious results for total and free prostate-specific antigen (PSA); sometimes really “a riddle wrapped in a mystery inside an enigma”
  33. Reply to: Spurious results for total and free prostate-specific antigen (PSA); sometimes really “a riddle wrapped in a mystery inside an enigma”
  34. Spike vs. nucleocapsid serum antigens for COVID-19 diagnosis and severity assessment
  35. A rapid semi-quantitative test for determination of SARS-CoV-2 antibody levels
  36. Diagnostic potential of leukocyte differential and cell population data in prediction of COVID-19 among related viral and bacterial infections at Emergency Department
  37. Added value of drug-laboratory test interaction alerts in test result authorisation
  38. Pre-analytical considerations for the analysis of uracil and 5,6-dihydrouracil in heparin plasma
  39. Rare unstable and low oxygen affinity haemoglobin variant, Hb Hazebrouck, detected on Sysmex XN-9000
  40. Multicancer early detection
Downloaded on 30.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2021-1227/html?lang=en
Scroll to top button